ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 050,51
1,37%
Dow Jones
41 433,48
0,00%
DAX
22 743,05
1,91%
Brent Oil
70,245
0,76%
Bitcoin
83 816,78
1,17%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Aadi Bioscience Inc (AADI) Cours

Aadi Bioscience Inc

Aadi Bioscience Inc (AADI)

NASDAQ
1,91
-0,02
(-1,04%)
Fermé 11 Mars 9:00PM
Retardé de 15 minutes
1,98
0,07
( 3,66% )
Avant marché: 1:53PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,98
Prix Achat
1,95
Prix Vente
1,97
Volume échangé
360
0,00 Fourchette du Jour 0,00
1,21 Plage de 52 semaines 3,812
Cap du marché
48,802M
Clôture Veille
1,91
Ouverture
-
Dernière Transaction
300
@
1.98
(formt)
Dernière heure de transaction
13:34:17
Volume financier
-
VWAP
-
Volume moyen (3 m)
391 671
Actions en circulation
24 647 392
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,72
Bénéfice par action (BPA)
-2,67
Chiffre d'affairess
24,35M
Bénéfice net
-65,77M

À propos de Aadi Bioscience Inc

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other ... Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.aadibio.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Aadi Bioscience Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker AADI. Le dernier cours de clôture d'Aadi Bioscience était de US$1,91. Au cours de la dernière année, les actions de Aadi Bioscience ont été négociées dans une fourchette de prix de US$ 1,21 à US$ 3,812.

Aadi Bioscience compte actuellement 24 647 392 actions en circulation. La capitalisation boursière d'Aadi Bioscience est de US$47,08 million. Aadi Bioscience a un ratio cours/bénéfice (ratio PE) de -0.72.

AADI Dernières nouvelles

Plus de nouvelles

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
il y a 14 heures
AADI (-1,04%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
10 Mars 2025
AADI (-1,04%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
AADI (-1,04%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
AADI (-1,04%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
AADI (-1,04%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
AADI (-1,04%)

Form 8-K - Current report
Edgar (US Regulatory)
04 Mars 2025
AADI (-1,04%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.28-12.3893805312.262.281.854041352.02921497CS
4-0.68-25.56390977442.662.941.851704342.24350311CS
12-0.42-17.52.43.8121.853916713.09374295CS
260.115.882352941181.873.8121.762386802.8211681CS
52-0.17-7.906976744192.153.8121.212445292.25561171CS
156-16.98-89.556962025318.9620.091.212015165.07045359CS
260-28.02-93.43032.991.211921987.1150575CS

AADI - Frequently Asked Questions (FAQ)

What is the current Aadi Bioscience share price?
The current share price of Aadi Bioscience is US$ 1,98
How many Aadi Bioscience shares are in issue?
Aadi Bioscience has 24 647 392 shares in issue
What is the market cap of Aadi Bioscience?
The market capitalisation of Aadi Bioscience is USD 47,08M
What is the 1 year trading range for Aadi Bioscience share price?
Aadi Bioscience has traded in the range of US$ 1,21 to US$ 3,812 during the past year
What is the PE ratio of Aadi Bioscience?
The price to earnings ratio of Aadi Bioscience is -0,72
What is the cash to sales ratio of Aadi Bioscience?
The cash to sales ratio of Aadi Bioscience is 1,93
What is the reporting currency for Aadi Bioscience?
Aadi Bioscience reports financial results in USD
What is the latest annual turnover for Aadi Bioscience?
The latest annual turnover of Aadi Bioscience is USD 24,35M
What is the latest annual profit for Aadi Bioscience?
The latest annual profit of Aadi Bioscience is USD -65,77M
What is the registered address of Aadi Bioscience?
The registered address for Aadi Bioscience is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aadi Bioscience website address?
The website address for Aadi Bioscience is www.aadibio.com
Which industry sector does Aadi Bioscience operate in?
Aadi Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VSTEVast Renewable Ltd
US$ 0,972
(94,44%)
81,49M
STISolidion Technology Inc
US$ 0,1828
(44,96%)
124,17M
TOIOncology Institute Inc
US$ 0,903
(43,11%)
25
HFBLHome Federal Bancorp Inc of Louisiana
US$ 17,99
(42,38%)
1
CSPICSP Inc
US$ 22,00
(41,94%)
16
HEPAHepion Pharmaceuticals Inc
US$ 0,0507
(-39,64%)
16,4M
IRBTiRobot Corporation
US$ 4,12
(-34,71%)
1,75M
ZYXIZynex Inc
US$ 4,7282
(-32,45%)
84,12k
NVEENV5 Global Inc
US$ 12,12
(-31,80%)
691
APDNApplied DNA Sciences Inc
US$ 0,1008
(-31,43%)
2,43M
STISolidion Technology Inc
US$ 0,1836
(45,60%)
124,23M
VSTEVast Renewable Ltd
US$ 0,9721
(94,46%)
81,5M
AREBAmerican Rebel Holdings Inc
US$ 0,361
(18,79%)
39,48M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,8399
(11,76%)
30,49M
HCTIHealthcare Triangle Inc
US$ 0,4466
(37,42%)
21,33M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces